Ligand Pharmaceuticals
Ligand Pharmaceuticals Incorporated, a biotechnology company, focuses on the discovery and early-stage development of pharmaceuticals for.
Market cap
$2.2b
Enterprise value
$2.0b
Share price
$113.68 LGND
loading funding rounds…
| USD | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | 49 % | (29 %) | (33 %) | 27 % | 16 % | 19 % | 17 % |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | 42 % | 4 % | 39 % | 7 % | 46 % | 68 % | - |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | 21 % | (17 %) | 40 % | (2 %) | - | 35 % | 40 % |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| R&D % of revenue | 25 % | 18 % | 19 % | 13 % | - | - | - |
Source: Company filings or news article, Equity research estimates
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments analysisEdit
Investments by Ligand Pharmaceuticals
Edit
exited
ACQUISITION by Ligand Pharmaceuticals Sep 2008
ACQUISITION by Ligand Pharmaceuticals Nov 2020
exited
ACQUISITION by Ligand Pharmaceuticals Aug 2020
ACQUISITION by Ligand Pharmaceuticals Oct 2017
ACQUISITION by Ligand Pharmaceuticals Oct 2009
ACQUISITION by Ligand Pharmaceuticals Dec 2009
exited